High expression of IL-8 can increase the dissemination of cancer cells, while anti-IL-8 treatment exhibits suppression of angiogenesis at the primary tumor site and decreased dissemination of breast cancer cells [53]. This evidence concerns the gene CXCL8 and breast carcinoma.